Anticipated Release Date: TBA ConnectWerx, a Partnership Intermediary of DOE in collaboration with the Arctic Energy Office and the Office of Technology Transitions will establish the Arctic Energy Seed Awards which will fund multiple awards to support the Read More
Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous Read More
Anticipated Release Date: Q3FY25 SIS will provide the capability to temporarily isolate or quarantine personnel to prevent the spread of a biological threat and safely evacuate patients for transfer off the ship. Capability will contain Read More
Anticipated Release Date: Q3FY26 ASPIRE will provide respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear threats that allows near normal operations by minimizing or eliminating physical and psychological burden and increasing Warfighter lethality. Read More
Anticipated Release: Q4FY25 Chemical indicators; Low-cost, easy to use, ultra-low SWaP modular open system based chemical detector that is widely distributed to the General Forces as an integrated kit for indication of chemical hazards; Provide Read More
Anticipated Release: Q3FY25 BCIS-ENBD will provide a ground-based isolation area for personnel infected or suspected of infection of biological organism or infectious disease and allows medical staff to monitor and/or treat while decreasing the risk Read More
Anticipated Release: Q4FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in the Countering Weapons of Mass Destruction (CWMD) Consortium. This Consortium releases numerous solicitations throughout the year, so even Read More
Anticipated Release: Q3FY25 This effort will solicit multidisciplinary teams for a competition involving prediction of synthetic binders, synthesis of identified binders, and assay development to include, but not limited to, lateral flow assays (LFAs) with Read More
Anticipated Release Date: Q3FY25 This topic aims to provide novel, low-burden masks for the general purpose warfighter utilizing innovative materials and custom manufacturing processes. These materials and processes will make these masks bespoke to users’ Read More
Anticipated Release Date: Q1FY25 New start OTA award for ADTX Responding to this opportunity requires membership in the Countering Weapons of Mass Destruction Consortium. This Consortium releases numerous solicitations throughout the year, so even if this Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.